NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InsiderRaymond R Hipp
This page shows the track record and history of HIPP RAYMOND R insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Raymond R Hipp in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Raymond R Hipp in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-11-16 70,000 42.2800 70,000 42.2800 2,959,600 178 36.62 -396,200 -13.39
2019-08-26 15,424 24.7900 15,424 24.7900 382,361
2019-08-23 600 25.0200 600 25.0200 15,012
2019-05-08 118,479 22.3600 118,479 22.3600 2,649,190
2019-05-07 31,521 22.6100 31,521 22.6100 712,690
2019-02-26 18,889 18.9000 18,889 18.9000 357,002

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NEO / NeoGenomics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2020-11-18 2020-11-16 4 HIPP RAYMOND R NEO Common Stock S - Sale D 42.2800 -70,000 -2,960 66,800
2020-06-01 2020-05-28 4 HIPP RAYMOND R NEO Stock Options (Right to Buy) A - Award D 28.54 3,448 3,448
2020-06-01 2020-05-28 4 HIPP RAYMOND R NEO Common Stock A - Award D 2,698 136,800
2019-08-27 2019-08-26 4 HIPP RAYMOND R NEO Common Stock S - Sale D 24.7900 -15,424 -382 134,102
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) M - Exercise D 11.60 -3,017 0
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) M - Exercise D 7.27 -3,333 3,334
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) M - Exercise D 9.11 -2,777 0
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Common Stock S - Sale D 25.0200 -600 -15 149,526
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 9.1100 2,777 25 150,126
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 7.2700 3,333 24 147,349
2019-08-27 2019-08-23 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 11.6000 3,017 35 144,016
2019-06-10 2019-06-06 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) A - Award D 22.52 4,269 4,269
2019-06-10 2019-06-06 4 HIPP RAYMOND R NEO Common Stock A - Award D 3,419 140,999
2019-05-09 2019-05-08 4 HIPP RAYMOND R NEO Common Stock S - Sale D 22.3600 -118,479 -2,649 137,580
2019-05-09 2019-05-07 4 HIPP RAYMOND R NEO Common Stock S - Sale D 22.6100 -31,521 -713 256,059
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) M - Exercise D 7.27 -3,333 6,667
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) M - Exercise D 9.11 -5,556 2,777
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) M - Exercise D 4.78 -10,000 0
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Common Stock S - Sale D 18.9000 -18,889 -357 287,580
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 7.2700 3,333 24 306,469
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 9.1100 5,556 51 303,136
2019-02-28 2019-02-26 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 4.7800 10,000 48 297,580
2018-06-05 2018-06-01 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) A - Award D 11.60 3,017 3,017
2018-06-05 2018-06-01 4 HIPP RAYMOND R NEO Common Stock A - Award D 15,564 287,580
2017-05-30 2017-05-30 4 HIPP RAYMOND R NEO Restricted Stock C - Conversion D 5,072 0
2017-05-30 2017-05-30 4 HIPP RAYMOND R NEO Restricted Stock C - Conversion D 2,150 0
2017-05-30 2017-05-30 4 HIPP RAYMOND R NEO Common Stock M - Exercise D 7,222 272,016
2017-05-30 2017-05-25 4 HIPP RAYMOND R NEO Restricted Stock A - Award D 8,667 8,667
2017-05-30 2017-05-25 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) A - Award D 7.27 7.2700 10,000 73 10,000
2016-07-29 2016-07-28 4 HIPP RAYMOND R NEO Stock Option (Right to Buy) A - Award D 9.11 9.1100 8,333 76 25,555
2016-07-29 2016-07-28 4 HIPP RAYMOND R NEO Restricted Stock A - Award D 5,072 7,222
2016-05-06 2016-04-20 4 HIPP RAYMOND R NEO Common Stock A - Award D 7.1500 2,150 15 266,944
2016-02-16 2015-05-06 5 HIPP RAYMOND R NEO Stock Option (Right to Buy) A - Award D 4.78 4.7800 10,000 48 10,000
2015-04-17 2015-04-16 4 HIPP RAYMOND R NEO Common Stock A - Award D 4.8200 2,080 10 264,794
2014-08-01 2014-04-15 4 HIPP RAYMOND R NEO Common Stock A - Award D 3.0500 3,000 9 3,000
2012-12-21 2012-12-20 4 HIPP RAYMOND R NGNM.OB Common Stock J - Other D 2.7500 188,571 519 235,714
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)